Cascadian Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

 Published On: Dec, 2017 |    No of Pages: 72 |  Published By: MarketLine | Format: PDF
Request Free Sample

Summary

Marketline's Cascadian Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Cascadian Therapeutics, Inc. since January2007.

Synopsis

Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Cascadian Therapeutics, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Cascadian Therapeutics, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Cascadian Therapeutics, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Cascadian Therapeutics, Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Cascadian Therapeutics, Inc.'s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Cascadian Therapeutics, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 11
Partnership – Overview 11
Partnership – Deal reports 12
CAPITAL RAISING 25
Capital Raising – Overview 25
Capital Raising – Deal reports 26
Divestments – Deal reports 54
PRIVATE EQUITY & OWNERSHIP 57
Private Equity and Ownership – Overview 57
Private Equity and Ownership – Deal reports 58
APPENDIX 62
Contact Us 62
About MarketLine Financial Deals Database 62
Deal Definition and Methodology 64
About MarketLine 71

List of Tables
Table 1: Cascadian Therapeutics M&A volume and value trend (2013-YTD2017)
Table 2: Cascadian Therapeutics M&A activity by geography (2013-YTD2017)
Table 3: Cascadian Therapeutics partnership volume and value trend (2013-YTD2017)
Table 4: Cascadian Therapeutics partnership trend by key deal type (2013-YTD2017)
Table 5: Cascadian Therapeutics capital raising volume and value trend (2013-YTD2017)
Table 6: Cascadian Therapeutics capital raising by deal type (2013-YTD2017)
Table 7: Cascadian Therapeutics private equity and ownership volume and value trend (2013-YTD2017)
Table 8: Cascadian Therapeutics private equity and ownership activity by deal type (2013-YTD2017)

List of Figures
Figure 1: Cascadian Therapeutics M&A volume and value trend (2013-YTD2017)
Figure 2: Cascadian Therapeutics M&A activity by geography (2013-YTD2017)
Figure 3: Cascadian Therapeutics partnership volume and value trend (2013-YTD2017)
Figure 4: Cascadian Therapeutics partnership trend by key deal type (2013-YTD2017)
Figure 5: Cascadian Therapeutics capital raising volume and value trend (2013-YTD2017)
Figure 6: Cascadian Therapeutics capital raising by deal type (2013-YTD2017)
Figure 7: Cascadian Therapeutics private equity and ownership volume and value trend (2013-YTD2017)
Figure 8: Cascadian Therapeutics private equity and ownership by deal type (2013-YTD2017)


If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.